Silver Book Fact

Annual Direct and Indirect Costs of Diabetic Retinopathy

Fact image

Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK: Including direct health costs and indirect societal and productivity costs. Diabetic Medicine. 2010; 29: 855-62. https://jdrf.org.uk/wp-content/uploads/2015/10/Hex-and-Bartlett.pdf

Heintz E, Wirehn A, Peebo B, Rosenqvist U, Levin L. Prevalence and Healthcare Costs of Diabetic Retinopathy: A population-based register study in Sweden. Diabetologia. 2010; 53(10): 2147-54. http://link.springer.com/article/10.1007%2Fs00125-010-1836-3

Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J. The Economic Burden of Diabetic Retinopathy in Germany in 2002. Graefes Arch Clin Exp Ophthalmol. 2008; 246(1): 151-9. http://link.springer.com/article/10.1007%2Fs00417-007-0573-x

Gonzalez J, Walker J, Einarson T. Cost-of-Illness Study of Type 2 Diabetes Mellitus in Colombia. 2009; 26(1): 55-63. http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892009000700009

Barcelo A, Aedo C, Rajpathak S, Robles S. The Cost of Diabetes in Latin America and the Caribbean. Bulletin of the World Health Organization. 2003; 81: 19-27. http://www.who.int/bulletin/Barcelo0103.pdf

Reference

Title
Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK: Including direct health costs and indirect societal and productivity costs
Publication
Diabetic Medicine
Publication Date
2010
Authors
Hex N, Bartlett C, Wright D, Taylor M, Varley D
Pages
855-62
URL
Read Full Resource
Title
Prevalence and Healthcare Costs of Diabetic Retinopathy: A population-based register study in Sweden
Publication
Diabetologia
Publication Date
2010
Authors
Heintz E, Wirehn A, Peebo B, Rosenqvist U, Levin L
Volume & Issue
Volume 53, Issue 10
Pages
2147-54
URL
Read Full Resource
Title
The Economic Burden of Diabetic Retinopathy in Germany in 2002
Publication
Graefes Arch Clin Exp Ophthalmol
Publication Date
2008
Authors
Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J
Volume & Issue
Volume 246, Issue 1
Pages
151-9
URL
Read Full Resource
Title
Cost-of-Illness Study of Type 2 Diabetes Mellitus in Colombia
Publication Date
2009
Authors
Gonzalez J, Walker J, Einarson T
Volume & Issue
Volume 26, Issue 1
Pages
55-63
URL
Read Full Resource
Title
The Cost of Diabetes in Latin America and the Caribbean
Publication
Bulletin of the World Health Organization
Publication Date
2003
Authors
Barcelo A, Aedo C, Rajpathak S, Robles S
Pages
19-27
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Future Impact of DR
    The rise of DR will disproportionately impacting the poorest populations, since 80% of people with diabetes live in low-middle income countries.  
  • People Affected Worldwide by DR
    By 2030, more than 191 million people around the world will be affected by DR—56 million with vision-threatening DR.  
  • Health care expenditures attributable to diabetes, by medical condition and type of service, 2002 (in millions of dollars)  
  • Approximately 1 in 5 health care dollars in the U.S. is spent caring for someone with diagnosed diabetes, while 1 in 10 health care dollars is attributed to diabetes.  
  • In 2034 a projected 44.1 million Americans will be diagnosed with diabetes.